- Home
- FIX vs MRNA Comparison
FIX vs MRNA Comparison
Compare FIX & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIX | MRNA |
|---|---|---|
| Founded | 1917 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.3B | 61.6B |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FIX | MRNA |
|---|---|---|
| Price | $1,645.93 | $198.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 12 |
| Target Price | ★ $1,798.60 | $34.27 |
| AVG Volume (30 Days) | 260.1K | ★ 13.5M |
| Earning Date | 04-23-2026 | 05-01-2026 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 97.81 | 21.77 |
| EPS | ★ 23.03 | N/A |
| Revenue | $9,101,641,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | $21.43 | $9.36 |
| Revenue Next Year | $13.14 | $15.43 |
| P/E Ratio | $72.03 | ★ N/A |
| Revenue Growth | ★ 29.52 | 4.29 |
| 52 Week Low | $770.47 | $22.28 |
| 52 Week High | $2,073.99 | $202.67 |
Technical Indicators
Market Signals| Indicator | FIX | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 51.74 | 75.87 |
| Support Level | $1,621.01 | $43.35 |
| Resistance Level | $1,695.57 | N/A |
| Average True Range (ATR) | 62.48 | 11.47 |
| MACD | 10.29 | 2.59 |
| Stochastic Oscillator | 62.20 | 86.71 |
Price Performance
Historical ComparisonAbout FIX Comfort Systems USA Inc.
Comfort Systems USA Inc provides comprehensive mechanical contracting services, including heating, ventilation, & air conditioning, or HVAC; plumbing; piping & controls; construction; and other electrical components. Projects are mainly for commercial, industrial, & institutional buildings, & tend to be geared toward HVAC. Revenue is roughly split between installation services for newly constructed facilities & maintenance services for existing buildings. The company installs & repairs products and systems throughout the United States. It operates in two segments, Mechanical services & Electrical services, the majority is from the Mechanical services segment.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.